| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.67▼ | 3.77▼ | 3.78▼ | 3.90▼ | 3.78▼ |
| MA10 | 3.70▼ | 3.80▼ | 3.81▼ | 3.89▼ | 3.98▼ |
| MA20 | 3.76▼ | 3.86▼ | 3.94▼ | 3.89▼ | 4.37▼ |
| MA50 | 3.80▼ | 3.99▼ | 3.92▼ | 4.07▼ | 3.82▼ |
| MA100 | 3.84▼ | 3.94▼ | 3.97▼ | 4.45▼ | 4.77▼ |
| MA200 | 3.95▼ | 3.97▼ | 4.06▼ | 3.92▼ | 3.71▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.013▼ | -0.032▼ | -0.003▼ | -0.083▼ |
| RSI | 31.203▼ | 33.273▼ | 36.117▼ | 41.010▼ | 44.144▼ |
| STOCH | 17.730▼ | 28.450 | 18.083▼ | 42.011 | 29.563 |
| WILL %R | -85.294▼ | -95.000▼ | -95.000▼ | -91.655▼ | -87.638▼ |
| CCI | -111.324▼ | -154.000▼ | -169.379▼ | -24.973 | -58.010 |
|
Friday, November 13, 2026 09:27 AM
Rezolute Inc. (NASDAQ:RZLT) on Friday achieved the primary efficacy endpoint in its ongoing open-label Phase 3 upLIFT study of ersodetug for tumor hyperinsulinism while pricing an underwritten ...
|
|
Friday, November 13, 2026 09:27 AM
Rezolute Inc. (NASDAQ:RZLT) on Friday achieved the primary efficacy endpoint in its ongoing open-label Phase 3 upLIFT study of ersodetug for tumor hyperinsulinism while pricing an underwritten ...
|
|
Friday, November 13, 2026 07:50 AM
Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biotechnology company developing treatments for rare metabolic diseases, announced that its ongoing Phase 3 upLIFT study of ersodetug in patients with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 4.36 | 4.60 | 3.60 | 3.65 | 5,531,771 |
| 12/11/26 | 4.06 | 4.125 | 3.85 | 3.87 | 1,088,432 |
| 11/11/26 | 4.10 | 4.155 | 3.99 | 4.07 | 974,183 |
| 10/11/26 | 3.93 | 4.205 | 3.90 | 4.02 | 1,604,761 |
| 09/11/26 | 3.99 | 4.20 | 3.79 | 3.87 | 2,454,609 |
| 06/11/26 | 3.67 | 3.90 | 3.59 | 3.88 | 1,519,706 |
| 05/11/26 | 3.93 | 3.97 | 3.5635 | 3.64 | 1,226,011 |
| 04/11/26 | 4.12 | 4.34 | 3.95 | 3.96 | 1,074,149 |
| 03/11/26 | 3.94 | 4.1301 | 3.90 | 4.01 | 919,232 |
| 02/11/26 | 3.98 | 4.02 | 3.745 | 3.88 | 844,863 |
|
|
||||
|
|
||||
|
|